· Investment Strategies · 3 sources · Updated · Verified
September 13–14 Investment News: Tandem $100M, Qupital $300M, Synapse $13M
Fresh Sep 13–14 tape: Tandem Health $100M Series B (EQT Scaleup’s first healthcare check), Qupital $300M Series C + ABS package, Synapse Analytics $13M Partech Series A — plus what we skipped (NeoCognition April reprint, Mecka talks).
By Venture Capital Tracker Editorial
September 13–14 printed three financings worth tracking after the Sep 10–12 Motive cluster: European clinic AI, Hong Kong e-commerce trade finance, and MENA bank-owned credit decisioning.
Deep dives
| Date | Company | Amount | Stage | Lead / structure | Follow-up |
|---|---|---|---|---|---|
| Sep 14 | Tandem Health | $100M | Series B | Scaleup Europe Fund (EQT) — first healthcare check; $160M lifetime | Tandem memo |
| Sep 13–14 | Qupital | $300M combined | Series C + ABS | M Capital Series C anchor; MUFG + Quester ABS; split n/d | Qupital memo |
| Sep 14 | Synapse Analytics | $13M | Series A | Partech; Algebra Ventures + Silicon Badia; $17M lifetime | Synapse Analytics memo |
Why this set hangs together
- Scaleup Europe Fund is still writing European category checks after Mistral and TEC — Tandem extends that book into MDR-grade clinic AI.
- Qupital is a reminder that Asia fintech headlines often mix equity and structured credit; do not paste “$300M Series C” into a pure-equity table.
- Synapse Analytics is a naming trap and a thesis: regulated lenders buy AI when data stays inside the perimeter.
| Item | Why |
|---|---|
| NeoCognition “$40M seed” reprints dated Sep 13 | Primary close was April 21, 2026 (TechCrunch / PR Newswire) — stale aggregator |
| Mecka AI ~$500M Sequoia | TechCrunch talks, not closed |
| Pixxel $100M / Inspiren $70M / Boring / Positron / Clay | Already on main or open Sep 9–12 PRs |
Day context
Prior index: September 10–12 Motive / Xapien / physical AI. Month hub: September 2026 VC News.
Follow Venture Capital Tracker on Google
Add VCT as a preferred source to see more of our venture-capital reporting in Google Search.
Last updated:
Editorial note: AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.